Plain-English translation of NCT02970968 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Gastroparesis research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial tested a medication called tradipitant to see if it could help relieve symptoms of gastroparesis, a condition where the stomach doesn't empty food normally. Researchers divided participants into two groups: some received the medication for 4 weeks, while others received a placebo (a pill with no active ingredient) so they could fairly compare how well the treatment worked.
Gastroparesis can cause significant discomfort and affect quality of life, but current treatment options are limited. Researchers wanted to test whether this medication might offer a new way to help people manage their symptoms.
Participants first went through a screening phase where they tracked their symptoms in a diary for at least 4 weeks to confirm they qualified. Then they attended a baseline visit and were randomly assigned to take either the study medication or a placebo as an oral capsule once daily for 4 weeks. Throughout the trial, participants continued tracking their symptoms and attended follow-up visits so researchers could monitor how well the treatment worked.
AI-generated summary from trial data · Aug 24, 2026 · Not medical advice
United States